GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Short-Term Capital Lease Obligation

Renata (DHA:RENATA) Short-Term Capital Lease Obligation : BDT0 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Renata Short-Term Capital Lease Obligation?

Renata's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was BDT0 Mil.

Renata Short-Term Capital Lease Obligation Historical Data

The historical data trend for Renata's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata Short-Term Capital Lease Obligation Chart

Renata Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Renata Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Renata Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Renata Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Renata's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Renata (DHA:RENATA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
DHA:SQURPHARMA DHA:BXPHARMA DHA:BEACONPHAR DHA:ACMELAB DHA:ORIONINFU DHA:AFCAGRO ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX
Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Website
https://www.renata-ltd.com
Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata (DHA:RENATA) Headlines

No Headlines